Japanese CTO PCI Expert Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorKurashiki Central Hospital
About this trial
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
Eligibility criteria
Qualifiers
Thrombolysis in myocardial infarction trial (TIMI) 0
The occlusive period more than 3 months or unknown
The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
19,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Kurashiki Central Hospital
Lead sponsor
Japanese CTO PCI Expert Registry investigators
Collaborator
Source ClinicalTrials.gov